(Q52005839)
Statements
The cognitive effects of recombinant interleukin-2 (rIL-2) therapy: a controlled clinical trial using computerised assessments. (English)
1 reference
L G Walker
1 reference
K P Wesnes
1 reference
S D Heys
1 reference
M B Walker
1 reference
J Lolley
1 reference
O Eremin
1 reference
1 December 1996
1 reference
32A
1 reference
13
1 reference
2275-2283
1 reference